Karin Mayer
YOU?
Author Swipe
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literature Open
Leiomyosarcoma is a malignant soft tissue tumor that still has a very poor prognosis in the metastatic stage, often lasting only several months. In addition to surgery and radiotherapy, the conventional treatment of this tumor entity is de…
Figure S2 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Incidence of treated patients in both groups between 2004 and 2016. This graph shows that there was no significant change in the treatment protocol (PRRT monotherapy/ or combination therapy PRRT + SSA and / or maintenance therapy with SSA)…
Table S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Subgroups: patients' characteristics.
Figure S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Consort diagram of the study population. At the beginning of the analyses 421 patients, treated with peptide receptor radionuclide therapy (PRRT), were assessed. Patients who did not meet the inclusion criteria were excluded. These were ma…
Table S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Subgroups: patients' characteristics.
Figure S2 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Incidence of treated patients in both groups between 2004 and 2016. This graph shows that there was no significant change in the treatment protocol (PRRT monotherapy/ or combination therapy PRRT + SSA and / or maintenance therapy with SSA)…
Data from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Purpose: Although somatostatin analogues (SSA) and peptide receptor radionuclide therapy (PRRT) are validated therapies in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET), it remains unclear whether SSA combin…
Data from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Purpose: Although somatostatin analogues (SSA) and peptide receptor radionuclide therapy (PRRT) are validated therapies in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET), it remains unclear whether SSA combin…
Figure S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy Open
Consort diagram of the study population. At the beginning of the analyses 421 patients, treated with peptide receptor radionuclide therapy (PRRT), were assessed. Patients who did not meet the inclusion criteria were excluded. These were ma…
Next Generation Sequencing in Pediatric Epilepsy Using Customized Panels: Size Matters Open
Introduction Next generation sequencing (NGS) with customized gene panels is a helpful tool to identify monogenic epilepsy syndromes. The number of genes tested within a customized panel may vary greatly. The aim of the present study was t…
Fetal tuberous sclerosis and diagnosis of paternal gonadal mosaicism Open
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder with high clinical variability. TSC is caused by pathogenic variants within the TSC1 or TSC2 gene, which regulate cell growth and proliferation, and affected individuals de…
Severe bleeding complications and multiple kidney transplants in a patient with tuberous sclerosis complex caused by a novel TSC2 missense variant Open
We presented an extremely severe case of tuberous sclerosis complex (TSC) in a female patient with recurring, life-threatening bleeding complications related to renal angiomyolipomas. Massive intratumoral hemorrhage required surgical remov…